We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Three studies showed that adults aged 20 to 50 years ...

Topline results that were recently released from Sydnexis’s phase 3 Study of Atropine for the Reduction of Myopia Progression ...

Please provide your email address to receive an email when new articles are posted on . Abnormal accommodative function and unbalanced input of binocular visual signals could contribute to myopia ...

Children and adolescents were at higher risk for myopic maculopathy progression if they had worse best-corrected visual acuity and longer axial length, among other risk factors. Myopic maculopathy ...

Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025 ...

Prior to this approval, the only other device indicated for slowing pediatric myopia progression was a contact lens. The Food and Drug Administration (FDA) has cleared the Essilor Stellest eyeglass ...

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study. The global prevalence of myopia was estimated to be 30% to 34% in 2020 and ...

EssilorLuxottica expands its myopia management platform with Essilor Stellest 2.0 lenses, smart glasses and an innovative pre-myopia solution ...

The Food and Drug Administration has authorized a spectacle lens from EssilorLuxottica for use in children with nearsightedness. EssilorLuxottica, which announced the de novo authorization on Thursday ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.